SUNDRY CLAUSES. SCHEDULE 1 ACORDA PATENT RIGHTS SCHEDULE 2 ASSIGNMENT AGREEMENT SCHEDULE 3 ELAN PATENT RIGHTS SCHEDULE 4 NDA TIMELINE SCHEDULE 5 RUSH/ACORDA LICENSE SCHEDULE 6 RUSH PAYMENTS AGREEMENT SCHEDULE 7 SPECIFICATIONS SCHEDULE 8 SUPPLY AGREEMENT SCHEDULE 9 TECHNOLOGY TRANSFER RESPONSIBILITES BETWEEN: (1) Elan Corporation, plc., a public limited company incorporated under the laws of Ireland, and having its registered office at ▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇ ▇, ▇▇▇▇▇▇▇ (“Elan”); and (2) Acorda Therapeutics, Inc., a corporation organized under the laws of the State of Delaware and having its principal office at ▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇ ▇▇▇▇▇▇ of America (“Acorda”).
Appears in 5 contracts
Sources: License Agreement (Acorda Therapeutics Inc), License Agreement (Acorda Therapeutics Inc), License Agreement (Acorda Therapeutics Inc)